Vardenafil (Respira Therapeutics)

N/A

Report date: 2025/12/25 15:59:57

Base Information

Drug NameVardenafil (Respira Therapeutics)
Drug Alias NameVardenafil inhalation powder (Respira Therapeutics)RT-234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRespira Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRespira Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A